NAD+ Precursors (NR/NMN)

Nicotinamide Riboside and Nicotinamide Mononucleotide are used to elevate cellular NAD+ levels, which decline with age. While animal models show promise for sirtuin activation and mitochondrial rescue, human clinical data regarding measurable geroprotective outcomes remains mixed.